Home > Products > M2 & TCR (Vβ8) > Recombinant Anti-M2 x Anti-TCR (Vβ8) Bispecific Antibody (IgG-Fv)

Recombinant Anti-M2 x Anti-TCR (Vβ8) Bispecific Antibody (IgG-Fv)  (BSGV-180)

Recombinant Anti-M2 x Anti-TCR (Vβ8) Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-M2 antibody variable domain is fused to the C terminal of an IgG of anti-TCR (Vβ8) antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can retarget T cells to virus-infected cells. It is designed for the research of Influenza virus infection therapy.

Specifications

Targets
M2 & TCR (Vβ8)
Type
IgG-Fv
Species Reactivity
Human
Target 1
M2
Host Animal 1
Mouse
Target 2
TCR (Vβ8)
Host Animal 2
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
Influenza virus infection

Targets

Target 1
M2
Gene ID
UniProt ID
Alternative Names
influenza virus M2 protein;M2
Target 2
TCR (Vβ8)
Gene ID
Alternative Names
Trbv8; T cell receptor beta variable 8; TCR; T-cell receptor

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-M2 x Anti-TCR (Vβ8) Bispecific Antibody (IgG-Fv) (BSGV-180). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "M2 & TCR (Vβ8)"
See other bsAb targets related to "TCR (Vβ8)"

Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: